Q3 2023 |
252 |
$515M |
+$9.74M |
-$74.4M |
-$64.7M |
AAPL, MSFT, IVV, VTI, XOM
|
13F-HR |
10/19/2023, 03:00 PM |
Q2 2023 |
274 |
$603M |
+$34.5M |
-$19.3M |
+$15.2M |
AAPL, MSFT, IVV, VTI, XOM
|
13F-HR |
8/7/2023, 06:03 PM |
Q1 2023 |
260 |
$553M |
+$14.5M |
-$48.2M |
-$33.6M |
MSFT, AAPL, IVV, VTI, XOM
|
13F-HR |
5/8/2023, 02:12 PM |
Q4 2022 |
268 |
$556M |
+$72.1M |
-$32.1M |
+$40M |
VUG, MSFT, AAPL, IVV, VTI
|
13F-HR |
2/6/2023, 05:12 PM |
Q3 2022 |
254 |
$476M |
+$50.9M |
-$22.4M |
+$28.6M |
MSFT, AAPL, IVV, VTI, XOM
|
13F-HR |
11/1/2022, 01:52 PM |
Q2 2022 |
266 |
$486M |
+$26.8M |
-$28.7M |
-$1.83M |
MSFT, AAPL, IVV, VTI, JNJ
|
13F-HR |
8/10/2022, 02:55 PM |
Q1 2022 |
288 |
$583M |
+$84.2M |
-$39.6M |
+$44.6M |
MSFT, AAPL, IVV, AMZN, VTI
|
13F-HR |
5/4/2022, 10:34 AM |
Q4 2021 |
269 |
$568M |
+$35.3M |
-$122M |
-$86.3M |
AAPL, MSFT, IVV, AMZN, VTI
|
13F-HR |
2/10/2022, 04:40 PM |
Q3 2021 |
275 |
$624M |
+$17.4M |
-$62.3M |
-$44.9M |
MRNA, MSFT, AAPL, IVV, AMZN
|
13F-HR |
11/4/2021, 07:09 PM |
Q2 2021 |
267 |
$632M |
+$33.1M |
-$5.49M |
+$27.6M |
MRNA, MSFT, AAPL, IVV, AMZN
|
13F-HR |
8/4/2021, 12:36 PM |
Q1 2021 |
245 |
$523M |
+$41M |
-$43.4M |
-$2.44M |
MSFT, AAPL, IVV, AMZN, VTI
|
13F-HR |
5/12/2021, 09:10 AM |
Q4 2020 |
805 |
$645M |
+$58.7M |
-$18.6M |
+$40.1M |
MRNA, MSFT, AAPL, IVV, AMZN
|
13F-HR |
2/5/2021, 01:43 PM |
Q3 2020 |
602 |
$516M |
+$34.6M |
-$29.9M |
+$4.67M |
MRNA, MSFT, AAPL, IVV, AMZN
|
13F-HR |
10/16/2020, 05:14 PM |
Q2 2020 |
563 |
$490M |
+$23.3M |
-$75.8M |
-$52.5M |
MRNA, MSFT, AAPL, IVV, AMZN
|
13F-HR |
7/20/2020, 10:26 AM |
Q1 2020 |
529 |
$395M |
+$23.4M |
-$63.4M |
-$40M |
MRNA, MSFT, AAPL, IVV, AMZN
|
13F-HR |
4/24/2020, 08:13 AM |
Q4 2019 |
530 |
$464M |
+$22M |
-$76M |
-$54M |
MRNA, MSFT, AAPL, JPM, XOM
|
13F-HR |
2/5/2020, 12:23 PM |
Q3 2019 |
545 |
$471M |
+$14M |
-$28M |
-$14M |
MRNA, MSFT, AAPL, JPM, XOM
|
13F-HR |
11/5/2019, 01:29 PM |
Q2 2019 |
555 |
$474M |
+$103M |
-$18.1M |
+$84.7M |
MRNA, MSFT, AAPL, XOM, JPM
|
13F-HR |
7/31/2019, 02:39 PM |
Q1 2019 |
507 |
$378M |
+$8.27M |
-$19.7M |
-$11.4M |
MSFT, XOM, AAPL, JNJ, JPM
|
13F-HR |
4/15/2019, 11:11 AM |
Q4 2018 |
494 |
$347M |
+$19.7M |
-$22.7M |
-$3M |
MSFT, EFA, XOM, AAPL, JNJ
|
13F-HR |
2/8/2019, 02:48 PM |
Q3 2018 |
520 |
$405M |
+$23.7M |
-$14.9M |
+$8.83M |
MSFT, AAPL, XOM, JNJ, JPM
|
13F-HR |
10/30/2018, 04:10 PM |
Q2 2018 |
557 |
$370M |
+$12.2M |
-$12.5M |
-$367K |
XOM, AAPL, MSFT, EFA, JNJ
|
13F-HR |
8/10/2018, 06:00 PM |
Q1 2018 |
577 |
$365M |
+$6.37M |
-$14.2M |
-$7.86M |
XOM, MSFT, AAPL, EFA, JNJ
|
13F-HR |
4/30/2018, 11:43 AM |
Q4 2017 |
777 |
$382M |
+$14.3M |
-$19.8M |
-$5.5M |
XOM, JNJ, AAPL, EFA, MSFT
|
13F-HR |
2/13/2018, 02:02 PM |
Q3 2017 |
700 |
$369M |
+$20.2M |
-$16.1M |
+$4.16M |
XOM, EFA, JNJ, AAPL, MSFT
|
13F-HR |
11/9/2017, 03:13 PM |
Q2 2017 |
509 |
$353M |
+$17.7M |
-$17.3M |
+$469K |
XOM, EFA, JNJ, GE, AAPL
|
13F-HR |
8/11/2017, 04:42 PM |
Q1 2017 |
515 |
$346M |
+$28.5M |
-$13.2M |
+$15.3M |
XOM, GE, EFA, JNJ, MSFT
|
13F-HR |
5/4/2017, 04:24 PM |
Q4 2016 |
483 |
$319M |
+$20.3M |
-$4.41M |
+$15.9M |
XOM, GE, EFA, JNJ, JPM
|
13F-HR |
1/6/2017, 11:29 AM |
Q3 2016 |
452 |
$296M |
+$18.1M |
-$11.8M |
+$6.26M |
XOM, EFA, GE, JNJ, IBM
|
13F-HR |
11/10/2016, 10:45 AM |
Q2 2016 |
467 |
$287M |
+$58.7M |
-$6.25M |
+$52.5M |
XOM, GE, EFA, JNJ, IBM
|
13F-HR |
8/8/2016, 04:41 PM |
Q1 2016 |
451 |
$226M |
+$7.69M |
-$13.9M |
-$6.21M |
EFA, XOM, GE, IBM, MSFT
|
13F-HR |
5/12/2016, 10:37 AM |
Q4 2015 |
470 |
$227M |
+$32.4M |
-$8.46M |
+$23.9M |
EFA, XOM, GE, MSFT, IBM
|
Restatement |
5/19/2016, 12:33 PM |
Q3 2015 |
407 |
$191M |
+$27.3M |
-$7.61M |
+$19.7M |
EFA, XOM, GE, IBM, JNJ
|
Restatement |
5/19/2016, 12:09 PM |
Q2 2015 |
312 |
$184M |
+$2.44M |
-$7.14M |
-$4.7M |
EFA, XOM, GE, IBM, PFE
|
13F-HR |
8/13/2015, 02:47 PM |
Q1 2015 |
319 |
$193M |
$0 |
$0 |
|
EFA, XOM, GE, IBM, CNI
|
13F-HR |
5/12/2015, 02:56 PM |